Observational Study to Assess a 6-months Treatment With Gladem

Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression

NCT01557946 ·Status: COMPLETED ·Phase: PHASE4

The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression

NCT00125957 ·Status: COMPLETED ·Phase: PHASE3

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

NCT04532749 ·Status: TERMINATED ·Phase: PHASE3

Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms

NCT01919216 ·Status: COMPLETED ·Phase: PHASE4

Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)

NCT03310281 ·Status: COMPLETED ·Phase: NA

The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients

NCT05030623 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

NCT02669030 ·Status: UNKNOWN ·Phase: PHASE4

Lamotrigine in Treatment Resistant Depression in Adolescents

NCT00284791 ·Status: TERMINATED ·Phase: NA

TRIAD - Treatment of Insomnia and Depression

NCT00767624 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression

NCT00232167 ·Status: TERMINATED ·Phase: PHASE3

An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder

NCT01587118 ·Status: COMPLETED ·Phase: PHASE4

Treatment of Mild and Subthreshold Depressive Disorders

NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4

Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors

NCT00296517 ·Status: COMPLETED ·Phase: PHASE3

Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

NCT06860958 ·Status: RECRUITING ·Phase: PHASE3

The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder

NCT01418638 ·Status: UNKNOWN

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

NCT03018340 ·Status: COMPLETED ·Phase: PHASE2

Tracking Response to Antidepressants in Advance of Investigational Trials

NCT04748276 ·Status: UNKNOWN

Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder

NCT00611923 ·Status: COMPLETED ·Phase: PHASE4

A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

NCT01607593 ·Status: COMPLETED

STILDEP: Zolpidem in Depressive and Dysthimic Patients

NCT00292734 ·Status: COMPLETED ·Phase: PHASE4

SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims

NCT00114374 ·Status: TERMINATED ·Phase: PHASE3

Intensive Accelerated iTBS for the Treatment-Resistant Depression

NCT06166082 ·Status: COMPLETED ·Phase: NA

An 8-week, Open-label Study to Evaluate the Effect of Sertraline on Polysomnogram in Depressive Patients With Insomnia

NCT01032434 ·Status: COMPLETED ·Phase: NA

Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD

NCT06141876 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

NCT00149825 ·Status: COMPLETED ·Phase: PHASE2